To determine whether the inhibition of the tumor development by ciglitazone is due to inhibition of proliferation, apoptosis, or both, we evaluated Ki67 expression and caspase 3 activation on tumor tissue sections by immunohistochemical analysis. Here, CASP3 is linked to neoplasm.